Paper41599159
Effect of Treatment with a Combination of Dichloroacetate and Valproic Acid on Adult Glioblastoma Patient-Derived Primary Cells Xenografts on the Chick Embryo Chorioallantoic Membrane.
Skredėnienė R and 5 others. Pharmaceutics, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Effect of Treatment with a Combination of Dichloroacetate and Valproic Acid on Adult Glioblastoma Patient-Derived Primary Cells Xenografts on the Chick Embryo Chorioallantoic Membrane. Papers, record 41599159. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41599159
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of Treatment with a Combination of Dichloroacetate and Valproic Acid on Adult Glioblastoma Patient-Derived Primary Cells Xenografts on the Chick Embryo Chorioallantoic Membrane.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P-MIP-20-36 | Lietuvos Mokslo Taryba | PubMed |
Source PubMed
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23333277 | Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. | Cell Rep | 2013 | https://conductscience.org/library/papers/23333277 | PubMed |
| 2 | 33667657 | Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy: A systematic review. | Crit Rev Oncol Hematol | 2021 | https://conductscience.org/library/papers/33667657 | PubMed |
| 3 | 19487819 | Biomarkers for epithelial-mesenchymal transitions. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19487819 | PubMed |
| 4 | 37886397 | GFAP serves as a structural element of tunneling nanotubes between glioblastoma cells and could play a role in the intercellular transfer of mitochondria. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37886397 | PubMed |
| 5 | 30519355 | GFAP expression is influenced by astrocytoma grade and rs2070935 polymorphism. | J Cancer | 2018 | https://conductscience.org/library/papers/30519355 | PubMed |
| 6 | 28642877 | The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28642877 | PubMed |
| 7 | 38140056 | Preclinical Study in Mouse Thymus and Thymocytes: Effects of Treatment with a Combination of Sodium Dichloroacetate and Sodium Valproate on Infectious Inflammation Pathways. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38140056 | PubMed |
| 8 | 21499304 | Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate. | Oncogene | 2011 | https://conductscience.org/library/papers/21499304 | PubMed |
| 9 | 25855378 | Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function. | Cancer Res | 2015 | https://conductscience.org/library/papers/25855378 | PubMed |
| 10 | 32682428 | The application of histone deacetylases inhibitors in glioblastoma. | J Exp Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32682428 | PubMed |
| 11 | 15741301 | Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer. | Jpn J Clin Oncol | 2005 | https://conductscience.org/library/papers/15741301 | PubMed |
| 12 | 33716589 | The Effectiveness of Dichloroacetate on Human Glioblastoma Xenograft Growth Depends on Na+ and Mg2+ Cations. | Dose Response | 2021 | https://conductscience.org/library/papers/33716589 | PubMed |
| 13 | 28183348 | Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies. | J Transl Med | 2017 | https://conductscience.org/library/papers/28183348 | PubMed |
| 14 | 29498669 | Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field. | J Clin Med | 2018 | https://conductscience.org/library/papers/29498669 | PubMed |
| 15 | 40575409 | Brain CD73 modulates interferon signaling to regulate glioblastoma invasion. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/40575409 | PubMed |
| 16 | 33103432 | Why All the Fuss about Oxidative Phosphorylation (OXPHOS)? | J Med Chem | 2020 | https://conductscience.org/library/papers/33103432 | PubMed |
| 17 | 26063767 | Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism. | Mol Cancer Ther | 2015 | https://conductscience.org/library/papers/26063767 | PubMed |
| 18 | 32478924 | Management of glioblastoma: State of the art and future directions. | CA Cancer J Clin | 2020 | https://conductscience.org/library/papers/32478924 | PubMed |
| 19 | 31910904 | Applications of patient-derived tumor xenograft models and tumor organoids. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/31910904 | PubMed |
| 20 | 41012498 | Comparison of the Effect of the Combination of Sodium Valproate and Sodium Dichloroacetate on the Expression of SLC12A2, SLC12A5, CDH1, CDH2, EZH2, and GFAP in Primary Female Glioblastoma Cells with That of Temozolomide. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012498 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42395268 | Overexpression of EZH2 is associated with clinicopathological parameters and poor prognosis in gliomas. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42395268 |
Source PubMed
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EZH2 | 2146 | PubTator's text mining | https://conductscience.org/library/genes/2146 | NCBI Gene |
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
| IDH1 | 3417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
| PCNA | 5111 | PubTator's text mining | https://conductscience.org/library/genes/5111 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41599159
GET https://conductscience.org/api/papers/v1/41599159/references?page=2